1992
DOI: 10.1016/0267-6605(92)90079-9
|View full text |Cite
|
Sign up to set email alerts
|

Resorbable polymers for internal fixation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
16
0

Year Published

1993
1993
2010
2010

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 42 publications
(16 citation statements)
references
References 45 publications
0
16
0
Order By: Relevance
“…To be biocompatible, they should have no adverse effects on the implant recipient by inducing adverse inflammatory reactions and not being carcinogenic, teratogenic, or toxic (Gogolewski 1992). Similarly, they must be reproducibly processed into desired form and sterilized without being degraded.…”
Section: Discussionmentioning
confidence: 99%
“…To be biocompatible, they should have no adverse effects on the implant recipient by inducing adverse inflammatory reactions and not being carcinogenic, teratogenic, or toxic (Gogolewski 1992). Similarly, they must be reproducibly processed into desired form and sterilized without being degraded.…”
Section: Discussionmentioning
confidence: 99%
“…This means that the degradation of nanofibrous scaffolds progresses preferentially from the surface of the nanofibrous scaffolds or interface which contacts with the tissues of rat. It is deduced that some substance such as tissue enzymes facilitate the degradation (Gogolewski, 1992). After 4 weeks of implantation, the PLLA nanofibrous scaffold showed 28% decrease in crystallinity (86% to 58%) while the electrospun stereocomplexed PLA scaffold showed 12% decrease in crystallinity (61% to 49%) (Fig.…”
Section: Crystallinity Of Nanofibrous Scaffoldsmentioning
confidence: 95%
“…Medullary augmentation devices (10 × 120 mm) were meltextruded from poly(L-lactide) (PLLA) [3,4,9,10,17]. The PMMA used cement was Palacos (Essex Chemie AG, Lucerne).…”
Section: Methodsmentioning
confidence: 99%